JP2021534239A5 - - Google Patents
Info
- Publication number
- JP2021534239A5 JP2021534239A5 JP2021531465A JP2021531465A JP2021534239A5 JP 2021534239 A5 JP2021534239 A5 JP 2021534239A5 JP 2021531465 A JP2021531465 A JP 2021531465A JP 2021531465 A JP2021531465 A JP 2021531465A JP 2021534239 A5 JP2021534239 A5 JP 2021534239A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- fragment
- monoclonal antibody
- rsv
- binding fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862716184P | 2018-08-08 | 2018-08-08 | |
| US62/716,184 | 2018-08-08 | ||
| PCT/US2019/045775 WO2020033742A1 (en) | 2018-08-08 | 2019-08-08 | Improved rsv passive and active vaccines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021534239A JP2021534239A (ja) | 2021-12-09 |
| JP2021534239A5 true JP2021534239A5 (https=) | 2022-08-17 |
Family
ID=69415133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021531465A Pending JP2021534239A (ja) | 2018-08-08 | 2019-08-08 | Ｒｓｖの改善された受動的および能動的ワクチン |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US12246063B2 (https=) |
| EP (1) | EP3833677A4 (https=) |
| JP (1) | JP2021534239A (https=) |
| CA (1) | CA3107037A1 (https=) |
| WO (1) | WO2020033742A1 (https=) |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2949031A1 (de) * | 1978-12-15 | 1980-07-17 | Sandoz Ag | Vakzine |
| EP0777685B1 (en) * | 1994-08-25 | 1999-04-14 | Stichting Instituut voor Dierhouderij en Diergezondheid | Antigenic peptides derived from the g protein of rsv for type- and subtype-specific diagnosis of respiratory syncytial virus (rsv) infection |
| AUPO026596A0 (en) | 1996-06-05 | 1996-06-27 | Biomolecular Research Institute Limited | Viral peptide |
| CA2426312C (en) | 2000-10-18 | 2014-01-14 | Ralph A. Tripp | Compositions and methods for modulating rsv infection and immunity |
| US6818216B2 (en) | 2000-11-28 | 2004-11-16 | Medimmune, Inc. | Anti-RSV antibodies |
| US20040096451A1 (en) * | 2002-07-25 | 2004-05-20 | Young James F. | Methods of treating and preventing RSV, hMPV, and PIV using anti-RSV, anti-hMPV, and anti-PIV antibodies |
| US7368537B2 (en) | 2003-07-15 | 2008-05-06 | Id Biomedical Corporation Of Quebec | Subunit vaccine against respiratory syncytial virus infection |
| WO2009055711A2 (en) * | 2007-10-25 | 2009-04-30 | Trellis Bioscience, Inc. | Anti-rsv g protein antibodies |
| US8846056B2 (en) | 2009-08-04 | 2014-09-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control | Anti-RSV immunogens and methods of immunization |
| CN106008716B (zh) | 2010-07-07 | 2019-08-13 | 人工细胞科技公司 | 呼吸道合胞病毒抗原组合物和方法 |
| MX387277B (es) | 2013-03-14 | 2025-03-12 | Contrafect Corp | Composiciones basadas en anticuerpos neutralizantes suministrados intranasalmente para eficacia terapéutica aumentada. |
| EA035846B1 (ru) * | 2013-04-15 | 2020-08-20 | Янссен Вэксинс Энд Превеншн Б.В. | Антитела человека, связывающиеся с g-белком rsv |
| JO3555B1 (ar) * | 2015-10-29 | 2020-07-05 | Merck Sharp & Dohme | جسم مضاد يبطل فعالية فيروس الالتهاب الرئوي البشري |
| WO2017132550A1 (en) | 2016-01-28 | 2017-08-03 | The Brigham And Women's Hospital, Inc. | Detection of an antibody against a pathogen |
| CA3079604A1 (en) | 2017-10-13 | 2019-04-18 | Trellis Bioscience, Llc | Conformational epitopes in respiratory syncytial virus g protein central conserved region |
| US20200033307A1 (en) | 2018-07-25 | 2020-01-30 | Honeywell International Inc. | Method of determining an amount of water in a sample using a derivative of imidazole and a hydrogen halide donor |
-
2019
- 2019-08-08 EP EP19847266.4A patent/EP3833677A4/en not_active Withdrawn
- 2019-08-08 CA CA3107037A patent/CA3107037A1/en active Pending
- 2019-08-08 JP JP2021531465A patent/JP2021534239A/ja active Pending
- 2019-08-08 WO PCT/US2019/045775 patent/WO2020033742A1/en not_active Ceased
-
2021
- 2021-02-05 US US17/168,553 patent/US12246063B2/en active Active
-
2025
- 2025-01-17 US US19/028,538 patent/US20250195636A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024038040A5 (https=) | ||
| JP2023071956A5 (https=) | ||
| WO2021174595A1 (zh) | 一种抗新型冠状病毒的单克隆抗体及其应用 | |
| JP2011511624A5 (https=) | ||
| WO2018028635A1 (zh) | 一种寨卡病毒人源单克隆抗体及其应用 | |
| JP2023015301A5 (https=) | ||
| JP2011528902A5 (https=) | ||
| JP2011528901A5 (https=) | ||
| CN115043938B (zh) | SARS-CoV-2及其突变株的抗体及应用 | |
| JP2017500018A5 (https=) | ||
| JP2012504955A5 (https=) | ||
| JP2010521147A5 (https=) | ||
| CN1610697A (zh) | 戊型肝炎病毒单克隆抗体或其结合活性片段及其用途 | |
| CN114478758B (zh) | 靶向SARS-CoV-2的纳米抗体及制备方法和应用 | |
| CN114736291B (zh) | 特异性结合发热伴血小板减少综合征病毒的囊膜蛋白Gn的人源单克隆抗体及其用途 | |
| JP2017113019A5 (https=) | ||
| JP2017537084A5 (https=) | ||
| JP2018514193A5 (https=) | ||
| JP2013520487A5 (https=) | ||
| JP2022542670A5 (https=) | ||
| MX2025002112A (es) | Composiciones de proteina de fusion recombinante neuregulina-1 (nrg-1) humana y metodos para su uso | |
| JP5977346B2 (ja) | Ｂ型肝炎ウイルス表面抗原のエピトープおよびその使用 | |
| WO2023019724A1 (zh) | 单克隆抗体35b5及其制备方法和用途 | |
| CN111978400A (zh) | 一种裂谷热病毒人源单克隆抗体及其应用 | |
| RU2019123112A (ru) | Анти-il-5 антитела |